Patent · US Active

Anti-CD324 monoclonal antibodies and uses thereof

US10087258B2 · kind B2 · utility

0Cited by
17References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 16, 2016
Grant dateOct 2, 2018
Priority date—
Expiry dateNov 17, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.